KM

Kenzie Maclsaac

Partner at Cure Ventures

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biomarker Discovery
Statistical Computing
Machine Learning
Genomics
Text Mining
Data Analysis
Immunology
Oncology
Bioinformatics
Drug Discovery
Computational Biology
Biomarkers

Education

Work Experience

Cure Ventures

2022

  • Partner

    2022

Bristol Myers Squibb

2018 - 2022

  • Senior Director

    2021 - 2022

  • Director, Translational Bioinformatics

    2018 - 2021

FogPharma

2018 - 2018

  • Director of Translational Bioinformatics

    2018 - 2018

Novartis Institutes for BioMedical Research

2014 - 2018

  • Senior Investigator II - Bioinformatics

    2014 - 2018

Merck

2009 - 2014

  • Associate Principal Scientist

    2009 - 2014

    Genomics and target discovery for immunology and oncology drug discovery programs.

MIT

2009 - 2010

  • Research Affiliate

    2009 - 2010